COMPASS Pathways Plc American Depository Shares Financial Statements
NASDAQ: CMPSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
11.88+0.41 (+3.57%)
Market open · Delayed 15 min · as of Oct 9, 12:21 PM ET
COMPASS Pathways Plc American Depository Shares revenue and earnings
COMPASS Pathways Plc American Depository Shares reported a net loss of $287.9 million, compared with a loss of $155.1 million a year earlier. Diluted earnings per share came in at -$3.08.
Summary generated from market data by MetaCap's automated system. Methodology
COMPASS Pathways Plc American Depository Shares income statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 |
|---|---|---|---|---|---|---|---|
| Operating Expenses | 179.04M | 178.21M | 136.92M | 110.40M | 83.22M | 51.39M | 21.18M |
| Research & Development | 118.44M | 119.04M | 87.52M | 65.05M | 44.03M | 23.37M | 12.56M |
| Operating Income | -179.04M | -178.21M | -136.92M | -110.40M | -83.22M | -51.39M | -21.18M |
| Interest Expense | 4.52M | 4.48M | 2.20M | 0 | 0 | — | — |
| Other Income (Expense) | -111.30M | 24.68M | 19.23M | 19.31M | 11.68M | -8.91M | 1.58M |
| Pretax Income | -290.33M | -153.53M | -117.68M | -91.10M | -71.54M | -60.30M | -19.60M |
| Income Tax | -2.47M | 1.59M | 780.00K | 408.00K | 199.00K | 32.00K | 15.00K |
| Net Income | -287.86M | -155.12M | -118.46M | -91.50M | -71.74M | -60.33M | -19.61M |
| Net Income growth (YoY) | — | — | — | — | — | — | — |
| EPS (Basic) | -3.08 | -2.30 | -2.32 | -2.16 | -1.79 | -3.55 | -2.62 |
| EPS (Diluted) | -3.08 | -2.30 | -2.32 | -2.16 | -1.79 | -3.55 | -2.62 |
| Shares Outstanding (Basic) | 93.50M | 67.48M | 51.03M | 42.44M | 40.00M | 16.99M | 7.48M |
| Shares Outstanding (Diluted) | 93.50M | 67.48M | 51.03M | 42.44M | 40.00M | 16.99M | 7.48M |
| EBITDA | -178.82M | -177.97M | -136.68M | -110.07M | -83.05M | -51.28M | -21.12M |
This table shows 7 annual periods of COMPASS Pathways Plc American Depository Shares's income statement, from FY 2025 back to FY 2019, across 13 line items including operating expenses, research & development, operating income. Values in USD; B = billions, M = millions. Fiscal periods follow CMPS's reporting calendar. What is a income statement?